The future access to mifepristone, a drug central to medication abortions, now dangles in the balance as the Supreme Court gears up to hear pivotal arguments this Tuesday in the case of FDA v. Alliance for Hippocratic Medicine. This landmark case will scrutinize the FDA's decisions to relax restrictions on the drug in years past and could dramatically restrict its availability going forward. The Washington-based DC News Now reports that over 60% of all abortions in 2023 were carried out using mifepristone.
Developing in November 2022, the case began when the Alliance Defending Freedom (ADF) sued the FDA representing anti-abortion medical groups and physicians. They argue mifepristone brings complications for doctors saddled with treating side effects. Major medical organizations have, however, debunked the safety concerns touted by ADF. The FDA's approval of the medication in the year 2000 was challenged, with U.S. District Judge Matthew Joseph Kacsmaryk effectively backing ADF's claims in an April 2023 ruling, as mentioned by The Missouri Independent.
While the arguments are set, the "standing" of the anti-abortion groups and physicians to sue has been contested. The Biden administration, together with Danco Laboratories, argue that these plaintiffs suffered no real harm from the drug's approval, hence lacking a legal stance in court. Nevertheless, other states with anti-abortion leaning are readying their legal arsenals to challenge the FDA's decisions if given a chance, which some suggest could prolong the legal battle indefinitely if standing is denied in this instance. Thomas Jipping of the Heritage Foundation expressed to reporters during a foundation event that "If the abortion states had standing last year, the pro-life states would have standing this year," as obtained by Roll Call.
Adding depth to the stakes of the decision next Tuesday, another case concerning the intersection of abortion rights and emergency care is awaiting the Court's attention—the dispute between Idaho and the Biden administration over Idaho's restrictive six-week abortion ban and its application in emergency rooms.
